BRIEF-OncoMed initiates enrollment of phase 1B clinical trial of Brontictuzumab
 

BRIEF-OncoMed initiates enrollment of phase 1B clinical trial of Brontictuzumab
* OncoMed initiates enrollment of phase 1B clinical trial of Brontictuzumab for the treatment of metastatic colorectal cancer patients Source text for Eikon: Further company coverage: http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...WM:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...WM:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/4OyjuJ0VAnk